New arthritis drug tested in kids for first time
NCT ID NCT06222034
Summary
This study is testing a medication called filgotinib in children and teenagers with juvenile idiopathic arthritis (JIA). The main goals are to see how the drug behaves in the body, if it's safe, and if kids can tolerate it. It's an early-phase study for children aged 8 to 18 whose current treatments aren't working well enough.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JUVENILE IDIOPATHIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asklepios Klinik Sankt Augustin GmbH
NOT_YET_RECRUITINGSankt Augustin, 53757, Germany
-
Bicêtre University Hospital
RECRUITINGLe Kremlin-Bicêtre, 94270, France
-
CHU Amiens - Hopital Nord
RECRUITINGAmiens, 80054, France
-
Children's university hospital Charité, Campus Virchow, SPZ
RECRUITINGBerlin, 13353, Germany
-
Great Ormond Street Hospital
NOT_YET_RECRUITINGLondon, WC1N 3JH, United Kingdom
-
Hamburger Zentrum fur Kinder und Jugendrheumatologie
RECRUITINGHamburg, 22081, Germany
-
Hospital Sant Joan de Deu
RECRUITINGBarcelona, 08950, Spain
-
Hospital Universitari Vall d'Hebron
RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitari i Politecnic La Fe
RECRUITINGValencia, 46026, Spain
-
Malopolskie Badania Kliniczne
RECRUITINGKrakow, 30-002, Poland
Conditions
Explore the condition pages connected to this study.